Cullinan Oncology Inc
NASDAQ:CGEM
Cullinan Oncology Inc
PP&E Gross
Cullinan Oncology Inc
PP&E Gross Peer Comparison
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cullinan Oncology Inc
NASDAQ:CGEM
|
PP&E Gross
$3.5m
|
CAGR 3-Years
228%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
PP&E Gross
$5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cullinan Oncology Inc's PP&E Gross?
PP&E Gross
3.5m
USD
Based on the financial report for Dec 31, 2023, Cullinan Oncology Inc's PP&E Gross amounts to 3.5m USD.
What is Cullinan Oncology Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
78%
Over the last year, the PP&E Gross growth was -33%. The average annual PP&E Gross growth rates for Cullinan Oncology Inc have been 228% over the past three years , 78% over the past five years .